A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex

Completed · Phase 3

Conditions studied: AIDS Dementia Complex, HIV Infections

In brief

The purpose of this study is to see if adding stavudine (d4T) to anti-HIV drug regimens (with or without zidovudine, ZDV) can improve symptoms of AIDS Dementia Complex (ADC, problems involving the brain or spinal cord) in HIV-positive patients.

Key facts

Study ID
NCT00002246
Run by
Bristol-Myers Squibb
People needed
20
Starts
1997-10-01
Expected to finish
1999-03-01
Last updated by the study team
2011-05-04

Who can join

Age: 13 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.